🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Cancer Trials Ireland clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Ireland register with Cancer Trials Ireland as lead sponsor. Synced 26 Sep 2026
13Current trials
7Recruiting now
7Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Cancer Trials Ireland is the lead sponsor of 13 current clinical trials in our Ireland register. 7 are recruiting patients now. The most common phase is Phase 2. The drugs named most often in its trials are Dexamethasone, Bortezomib and Cyclophosphamide. The most-studied condition is Breast Cancer.

ClinicalTrials.gov trials by status

  • Recruiting754%
  • Not yet open18%
  • Active, closed538%

Trials by phase

  • Phase 2646%
  • Observational215%
  • Not applicable215%
  • Phase 1/2215%
  • Phase 118%
01

Clinical trials sponsored by Cancer Trials Ireland

13 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)
NCT06149546 · Pancreatic Cancer
Not applicable Recruiting 2024-05 Ireland
Breast Cancer Proteomics and Molecular Heterogeneity
NCT01840293 · Primary Breast Cancer, Recurrent/Metastatic Breast Cancer
Observational Recruiting 2013-02 Ireland
Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases
NCT06078813 · Solid Tumor Spine Metastases
Phase 1/2 Recruiting 2023-11 Ireland
INSPIRE: INnovative SABR for Prostate Cancer All IREland
NCT07552168 · ClinicalTrials.gov ↗ · Prostate Adenocarcinoma
Phase 2 Recruiting 2026-04 Ireland
Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM)
NCT07425002 · ClinicalTrials.gov ↗ · Breast Cancer
Not applicable Recruiting 2025-11 Ireland
Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)
NCT06024824 · ClinicalTrials.gov ↗ · Pancreatic Adenocarcinoma
Phase 1/2 Recruiting 2024-01 Ireland
'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)
NCT04375904 · ClinicalTrials.gov ↗ · NSCLC/Oligometastatic Cancer (Single Lung Lesion)
Phase 2 Recruiting 2020-12 Ireland
OPTIMISE Lung SABR
NCT07777614 · Non Small Cell Lung Cancer
Phase 2 Not yet open 2026-10 Ireland
TAILORx Tissue Bank
NCT02050750 · Breast Cancer
Observational Active, closed 2013-12 Ireland
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
NCT04667663 · Multiple Myeloma
Phase 1 Active, closed 2021-12 Ireland
Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
NCT05123131 · Multiple Myeloma
Phase 2 Active, closed 2022-04 Ireland
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
NCT05710666 · ClinicalTrials.gov ↗ · HER2-positive Breast Cancer
Phase 2 Active, closed 2023-10 Ireland
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
NCT00951535 · ClinicalTrials.gov ↗ · Prostate Cancer
Phase 2 Active, closed 2009-07 Ireland

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Cancer Trials Ireland trials

7 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Cancer Trials Ireland trials

12 conditions
Breast Cancer2Multiple Myeloma2Pancreatic Cancer1Primary Breast Cancer1Recurrent/Metastatic Breast Cancer1Non Small Cell Lung Cancer1Solid Tumor Spine Metastases1Prostate Adenocarcinoma1Pancreatic Adenocarcinoma1HER2-positive Breast Cancer1NSCLC/Oligometastatic Cancer (Single Lung Lesion)1Prostate Cancer1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Ireland137

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Breast Cancer

SponsorTrials
Fudan University48
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University21
Second Affiliated Hospital, Zhejiang University, School of Medicine19
AstraZeneca15
Shengjing Hospital15
Pfizer12
Sichuan Baili Pharmaceutical12
Cancer Institute and Hospital, Chinese Academy of Medical Sciences12
Hoffmann-La Roche10
Ruijin Hospital10

Sponsors with the most current trials registered for this condition.

06

Questions about Cancer Trials Ireland trials

How many clinical trials does Cancer Trials Ireland sponsor?

Cancer Trials Ireland is the lead sponsor of 13 current trials on ClinicalTrials.gov in our Ireland register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Cancer Trials Ireland trials recruiting?

Yes. 7 of its 13 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Cancer Trials Ireland testing?

Its current trials name 7 drugs and biologicals as interventions. The most frequent are Dexamethasone (2), Bortezomib (1), Cyclophosphamide (1), Daratumumab (1) and Isatuximab (1). The number in brackets is how many of its trials name each drug.

Does Cancer Trials Ireland have clinical trials in Ireland?

Yes. 13 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.